Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing
Authors:
Open Access
- 1 January 2023
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 8 (1) , 23-30
Abstract
Importance: Statins reduce the risk of major adverse cardiovascular events, but less than one-half of individuals in America who meet guideline criteria for a statin are actively prescribed this medication.Objective: To evaluate whether nudges to clinicians, patients, or both increase initiation of statin prescribing during primary care visits.Design, Setting, and Participants: This cluster randomized clinical trial evaluated statin prescribing of 158 clinicians from 28 primary care practices including 4131 patients. The design included a 12-month preintervention period and a 6-month intervention period between October 19, 2019, and April 18, 2021.Interventions: The usual care group received no interventions. The clinician nudge combined an active choice prompt in the electronic health record during the patient visit and monthly feedback on prescribing patterns compared with peers. The patient nudge was an interactive text message delivered 4 days before the visit. The combined nudge included the clinician and patient nudges.Main Outcomes and Measures: The primary outcome was initiation of a statin prescription during the visit.Results: The sample comprised 4131 patients with a mean (SD) age of 65.5 (10.5) years; 2120 (51.3%) were male; 1210 (29.3%) were Black, 106 (2.6%) were Hispanic, 2732 (66.1%) were White, and 83 (2.0%) were of other race or ethnicity, and 933 (22.6%) had atherosclerotic cardiovascular disease. In unadjusted analyses during the preintervention period, statins were prescribed to 5.6% of patients (105 of 1876) in the usual care group, 4.8% (97 of 2022) in the patient nudge group, 6.0% (104 of 1723) in the clinician nudge group, and 4.7% (82 of 1752) in the combined group. During the intervention, statins were prescribed to 7.3% of patients (75 of 1032) in the usual care group, 8.5% (100 of 1181) in the patient nudge group, 13.0% (128 of 981) in the clinician nudge arm, and 15.5% (145 of 937) in the combined group. In the main adjusted analyses relative to usual care, the clinician nudge significantly increased statin prescribing alone (5.5 percentage points; 95% CI, 3.4 to 7.8 percentage points; P = .01) and when combined with the patient nudge (7.2 percentage points; 95% CI, 5.1 to 9.1 percentage points; P = .001). The patient nudge alone did not change statin prescribing relative to usual care (0.9 percentage points; 95% CI, −0.8 to 2.5 percentage points; P = .32).Conclusions and Relevance: Nudges to clinicians with and without a patient nudge significantly increased initiation of a statin prescription during primary care visits. The patient nudge alone was not effective.Trial Registration: ClinicalTrials.gov Identifier: NCT04307472Keywords
This publication has 27 references indexed in Scilit:
- National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013JAMA Cardiology, 2017
- Statin Use for the Primary Prevention of Cardiovascular Disease in AdultsJAMA, 2016
- Physician Peer Comparisons as a Nonfinancial Strategy to Improve the Value of CareJAMA, 2016
- A systematic review of interventions to improve adherence to statin medication: What do we know about what works?Preventive Medicine, 2016
- Effect of Financial Incentives to Physicians, Patients, or Both on Lipid LevelsJAMA, 2015
- Enhanced active choice: A new method to motivate behavior changeJournal of Consumer Psychology, 2011
- Structured Testing of 2×2 Factorial Effects: An Analytic Plan Requiring Fewer ObservationsThe American Statistician, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysisThe Lancet, 2008
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005